Library

F-Etonitazepin

Fluetonitazepyne is a benzimidazole derivative which is an opioid designer drug. It was first identified in Italy in July 2024, and subsequently isolated in Finland in early 2025 from the body fluids of five people who had died from opioid overdose. It has also been detected in Germany.

Classification

  • Chemical: 2-Benzylbenzimidazole opioid
  • Chemical: Opioid
  • Psychoactive: Depressant
  • Tag: Nitazene

Effects

  • Sedation
  • Motor Impairment
  • Respiratory Depression
  • Constipation
  • Pupil Constriction
  • Itchiness
  • Reduced Anxiety
  • Euphoria
  • Anxiety Suppression
  • Sadness
  • Dulled Perception
  • Internal Hallucination
  • Size Distortion
  • Warmth
  • Warm Flush

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

F-Etonitazepyne - DrugsPRO madde rehberi

F-Etonitazepyne: Fluetonitazepyne is a benzimidazole derivative which is an opioid designer drug. It was first identified in Italy in July 2024, and subsequently isolated in Finland in early 2025 from the body fluids of five people who had died from opioid overdose. It has also been detected in Germ

Related pages